Evidence map›Paper›PMID 33604503›Full record

ArticleRheumatology advances in practice2021

Successful treatment with the IL12/IL23 antagonist ustekinumab in a patient with refractory Takayasu arteritis.

Sebastian-Jonas Saur, Marius Horger, Jörg Henes

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Rheumatology advances in practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Advances and challenges in management of large vessel vasculitis.Rheumatology and immunology research · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sebastian-Jonas SaurRheumatology and Auto-inflammatory Diseases and Department of Internal Medicine II (Hematology, Oncology, Immunology and Rheumatology), Centre for Interdisciplinary Clinical Immunology.
Marius HorgerDepartment of Radiology, University Hospital Tübingen, Tübingen, Germany.
Jörg HenesRheumatology and Auto-inflammatory Diseases and Department of Internal Medicine II (Hematology, Oncology, Immunology and Rheumatology), Centre for Interdisciplinary Clinical Immunology.
University Children's Hospital Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33604503
PMCPMC7878844
OpenAlexW3121006234

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.